Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 

Online Report Subscribers, Click Here

Pricing and Ordering Information

 

European Markets for Prosthetic Vascular Grafts
Report #A270
- July 2013
182 Pages – 39 Exhibits – 7 Company Profiles


The number of patients in Europe receiving prosthetic grafts for aneurysm repair, coronary and peripheral vessel reconstruction, and hemodialysis access is expected to increase over the forecast period covered by this report due to the prevalence of both diabetes and cardiovascular disease in the region. In 2012, European sales of prosthetic vascular grafts totaled approximately $865 million; of this, endovascular stent-grafts for aortic aneurysm repair accounted for nearly 87% of sales, followed by peripheral vascular grafts with 10%, hemodialysis access grafts with 3%, and small-diameter CABG grafts with less than 1%. Over the forecast period covered by this report, total sales are expected to increase at a compound annual rate of 8.1%, reaching nearly $1.3 billion in the year 2017. Growth will be driven by technological advancements, population demographics, the growing prevalence of diabetes, and an increase in the number of interventional vascular surgeons in Europe.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European prosthetic vascular grafts market. Major topics covered by this report include an overview of selected cardiovascular diseases and disorders (e.g., aneurysm, coronary heart disease, diabetes, hypertension, and stroke); cardiovascular disease management options; and a discussion of products, competitors, and forecast markets for prosthetic vascular graft segments including endovascular stent-grafts for aortic aneurysm repair, hemodialysis access grafts, peripheral vascular grafts, and small-diameter CABG grafts.

Ordering Information

Title

Report# Publication
Date
List Price

European Markets for Prosthetic Vascular Grafts

A270

July 2013

$3,850

Order Online:
Single User only (Please call for corporate subscription pricing)
PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

EXECUTIVE SUMMARY

i.      Prosthetic Vascular Grafts

a.     Applications

b.     Product Categories

c      Hemodialysis Access Grafts

d.     Endovascular Stent-Grafts for Aortic Aneurysm Repair

e.     Peripheral Vascular Grafts

f.      Small-Diameter Coronary Artery Bypass Grafts

g.     Combined Market Analysis

 

Exhibit ES-1:    Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017

Exhibit ES-2:    Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair  Market Forecast, by Country, 2012-2017

Exhibit ES-3:    Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017

Exhibit ES-4:    Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017

Exhibit ES-5:    Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017

 

1. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS

1.1 Cardiovascular Diseases/Disorders

1.1.1 Coronary Heart Disease

1.1.1.1 Atherosclerosis

1.1.1.1.1 Description

1.1.1.1.2 Statistics

1.1.1.2 Angina Pectoris

1.1.1.2.1 Description

1.1.1.2.2 Statistics

1.1.1.3 Myocardial Infarction

1.1.1.3.1 Description

1.1.1.3.2 Statistics

1.1.2 Hypertension

1.1.2.1 Description

1.1.2.1 Statistics

1.1.3 Aneurysm

1.1.3.1 Description

1.1.3.2 Statistics

1.1.4 Stroke

1.1.4.1 Description

1.1.4.2 Statistics

1.1.5 Diabetes

1.1.5.1 Description

1.1.5.2 Statistics

1.2 Cardiovascular Disease Management Options

1.2.1 Medical Management

1.2.1.1 Lifestyle Changes

1.2.1.1.1 Dietary Modification

1.2.1.1.2 Smoking Cessation

1.2.1.2 Pharmaceuticals

1.2.1.2.1 Anticoagulants and Antiplatelet Drugs

1.2.1.2.2 Lipid-Lowering Drugs

1.2.1.2.3 Antihypertensive Drugs

1.2.1.2.4 Nitroglycerin Preparations

1.2.2 Intracoronary Heart Disease Diagnosis

1.2.2.1 Coronary Angiography

1.2.2.1.1 Description

1.2.2.1.2 Statistics

1.2.3 Coronary Artery Disease Treatment

1.2.3.1 Coronary Artery Bypass Graft Surgery

1.2.3.1.1 Less Invasive Coronary Artery Bypass Graft Techniques

1.2.3.2 Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting

1.2.3.3 Peripheral Percutaneous Revascularization Techniques

1.2.3.3.1 Percutaneous Transluminal Angioplasty and Peripheral Stenting

1.2.3.3.2 Peripheral Atherectomy

1.2.3.3.3 Peripheral Femoropopliteal Stenting

 

Exhibit 1-1:      Number of Deaths due to Cardiovascular Diseases/Disorders, by Gender

Exhibit 1-2:      2008, Prevalence of Hypercholesterolemia, by Gender

Exhibit 1-3:      Standard Angina Pectoris Classification

Exhibit 1-4:      30-Day Case Fatality Rates Following Hospital Admission for Acute Myocardial Infarction, Selected European Countries

Exhibit 1-5:      2008, Prevalence of Hypertension, by Gender

Exhibit 1-6:      Stroke, Hospital Discharge Rates, 2000 and 2009

Exhibit 1-7:      2008, Prevalence of Elevated Blood Glucose, by Gender

Exhibit 1-8:      2007, Daily Per-Person Consumption of Fats, Fruits, and Vegetables

Exhibit 1-9:      Tobacco Smoking Rate, by Gender

Exhibit 1-10:    2006/2007, Medication at Discharge for Patients with Coronary Heart Disease, Selected European Countries

Exhibit 1-11:    2007, Cardiac Catheterization Laboratories and Coronary Angiography Procedures, Selected European Countries

Exhibit 1-12:    2010, Coronary Artery Bypass Graft Surgery, Selected European Countries, by Type

Exhibit 1-13:    2010, Percutaneous Coronary Intervention/Stenting Procedures, Selected European Countries, by Type

Exhibit 1-14:    2010, Peripheral Vascular Disease Treatment Procedures, Selected European Countries, by Type

 

2. THE EUROPEAN PROSTHETIC VASCULAR GRAFTS MARKET

2.1 Prosthetic Vascular Grafting Applications

2.1.1 Aneurysm

2.1.2 Kidney Failure

2.1.3 Vascular Occlusion

2.2 Prosthetic Vascular Graft Categorization

2.2.1 Categorization by Graft Diameter

2.2.1.1 Large-Diameter Grafts

2.2.1.2 Medium-Diameter Grafts

2.2.1.3 Small-Diameter Grafts

2.2.2 Categorization by Graft Material

2.2.2.1 Polyester

2.2.2.2 Polytetrafluoroethylene

2.2.2.3 Polyurethane

2.2.2.4 Biological

2.2.2.4.1 Human Saphenous and Umbilical Veins

2.2.2.4.2 Tissue-Engineered Materials

2.2.3 Endovascular Stent-Grafts

2.2.3.1 Performance Requirements

2.2.3.2 Configurations

2.2.3.3 Endovascular Stent-Graft-Related Complications

2.3 Prosthetic Vascular Grafts Market

2.3.1 Market Drivers and Limiters

2.3.2 Hemodialysis Access Grafts

2.3.2.1 Market Forecast

2.3.2.2 Competitive Analysis

2.3.3 Endovascular Stent-Graft Systems for Aortic Aneurysm Repair

2.3.3.1 Market Forecast

2.3.3.2 Competitive Analysis

2.3.4 Peripheral Vascular Grafts

2.3.4.1 Market Forecast

2.3.4.2 Competitive Analysis

2.3.5 Small-Diameter Coronary Artery Bypass Grafts

2.3.5.1 Market Forecast

2.3.5.2 Competitive Analysis

2.3.6 Combined Market Forecast

 

Exhibit 2-1:      Indications for the Use of Prosthetic Vascular Grafts

Exhibit 2-2:      Interventions for the Treatment of Peripheral Vascular Occlusions

Exhibit 2-3:      Design Criteria for Synthetic Vascular Grafts

Exhibit 2-4:      Applications for Prosthetic Vascular Grafts, by Diameter

Exhibit 2-5:      2013, Selected Polyester Vascular Grafts

Exhibit 2-6:      2013, Selected Polytetrafluoroethylene Vascular Grafts

Exhibit 2-7:      2013, Selected Polyurethane Vascular Grafts

Exhibit 2-8:      Design Specifications for Endovascular Stent-Graft Systems

Exhibit 2-9:      Complications Associated with the Use of Endovascular Stent-Grafts for Abdominal Aortic Aneurysm Repair

Exhibit 2-10:    2013, Selected Endovascular Stent-Grafts for Aortic Aneurysm Repair

Exhibit 2-11:    Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017

Exhibit 2-12:    2012, Europe, Hemodialysis Access Grafts Market, Share by Supplier

Exhibit 2-13:    Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair, Market Forecast, by Country, 2012-2017

Exhibit 2-14:    2012, Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts Market, Share by Supplier

Exhibit 2-15:    2012, Europe, Endovascular Thoracic Aortic Aneurysm Stent-Grafts Market, Share by Supplier

Exhibit 2-16:    Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017

Exhibit 2-17:    2012, Europe, Peripheral Vascular Grafts Market, Share by Supplier

Exhibit 2-18:    Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017

Exhibit 2-19:    2012, Europe, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier

Exhibit 2-20:    Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017

 

3. COMPANY PROFILES

3.1       Atrium Medical Corporation/Getinge Group AB

3.2       C.R. Bard, Inc.

3.3       Cook Group, Inc.

3.4       W.L. Gore & Associates, Inc.

3.5       Maquet Vascular Interventions/Getinge Group AB

3.6       Medtronic, Inc.

3.7       Vascutek LTD/Terumo Corporation

 

APPENDIX:  COMPANY LISTING

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact custcare@informa.com. You can also call 1.908.748.1221 (or toll-free within the U.S. at 1.888.670.8900) or fax 1.646.666.9878.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home